PB 41 of 2022

National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 4)

I, Caroline Turnour, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated          28 April 2022   

CAROLINE TURNOUR

Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021)

1  Name

  This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 4).

  This instrument may also be cited as PB 41 of 2022.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021)

1. Schedule 1, entry for Metoprolol

Omit

Substitute

2.     Schedule 1, entry for Simvastatin

Omit

Substitute